Guangdong VTR Bio-Tech Co., Ltd. (SHE:300381)
7.42
+0.17 (2.34%)
May 12, 2026, 3:04 PM CST
Guangdong VTR Bio-Tech Market Cap
Guangdong VTR Bio-Tech has a market cap or net worth of 3.56 billion as of May 12, 2026. Its market cap has decreased by -3.76% in one year.
Market Cap
3.56B
Enterprise Value
3.09B
Revenue
842.50M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.42
Market Cap Chart
Since January 28, 2014, Guangdong VTR Bio-Tech's market cap has increased from 1.84B to 3.56B, an increase of 93.71%. That is a compound annual growth rate of 5.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2026 | 3.56B | 13.80% |
| Dec 31, 2025 | 3.13B | -7.12% |
| Dec 31, 2024 | 3.37B | -4.55% |
| Dec 29, 2023 | 3.53B | -4.20% |
| Dec 30, 2022 | 3.69B | -36.63% |
| Dec 31, 2021 | 5.82B | 9.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Guanhao Biotech | 3.85B |
| Novoprotein Scientific | 3.76B |
| Shanghai Shen Lian Biomedical | 3.68B |
| Zhejiang Shouxiangu Pharmaceutical | 3.48B |
| Beijing Kawin Technology Share-Holding | 3.44B |
| Yantai Zhenghai Biotechnology | 3.31B |
| Hubei Goto Biopharm | 3.29B |
| Shenzhen Bioeasy Biotechnology | 3.26B |